PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Oficina General de Investigación y Transferencia Tecnológica, Instituto Nacional de Salud, Lima, Perú.\', \'Pontificia Universidad Católica del Perú, Lima, Perú.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.17843/rpmesp.2021.381.6627
?:hasPublicationType
?:journal
  • Revista peruana de medicina experimental y salud publica
is ?:pmid of
?:pmid
?:pmid
  • 34190912
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.226
?:rankingScore_hIndex
  • 14
?:title
  • [The regulation of COVID-19 clinical trials in Peru].
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34190912>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34190912>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all